Evaluation of a Phyto Aromatherapy Treatment in the Management of Recurrent Cystitis

Launched by CENTRE HOSPITALIER UNIVERSITAIRE DE NICE · Feb 5, 2021

Keywords

ClinConnect Summary

This clinical trial is studying a new approach to help women who suffer from recurrent cystitis, which is a painful bladder condition that can happen four or more times a year. The researchers are exploring a treatment called phyto-aromatherapy, which uses natural plant-based remedies to both treat symptoms when they arise and to prevent future episodes. The treatment consists of two phases: the first focuses on relieving symptoms during an attack using special essential oils, and the second aims to prevent future flare-ups with a mix of medicinal plants that help balance the body and reduce pain and anxiety.

To participate in this trial, women aged 18 and older who have recurrent cystitis and can commit to regular consultations with a phyto-aromatherapy pharmacist every few months can apply. Participants will receive personalized care and guidance throughout the study. However, pregnant or breastfeeding women, those with certain health conditions, or those taking specific medications won't be eligible. This trial is currently active, and it aims to show whether this natural treatment can effectively help women manage their recurrent cystitis.

Gender

FEMALE

Eligibility criteria

• Inclusion Criteria:
• • Women aged 18 or older.
• • Affiliated to social security.
• • Presenting recurrent cystitis defined by a frequency of at least 4 episodes per year.
• • For women of childbearing age: effective contraception followed for at least 3 months prior to the start of the study and agreeing to keep it throughout the study period
• • Available to consult a phyto-aromatherapy pharmacist for an initial consultation and then every 3 months (M3, 6,9, 12) and then at 18 months.
• • Having been previously explored according to good practice and informed
• • Having signed the informed consent
• Exclusion Criteria:
• • Pregnant or breastfeeding women
• • Severe visceral deficiencies in the previous year.
• • Individualised psychiatric pathology.
• • Other progressive infectious pathologies requiring antibiotic treatment.
• • Taking anticoagulants.
• • Concomitant intake of non-drug treatments.